SCHEMBL752116

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL754559	0.86	LIPG (0.35)	LIPGALDH1A1POLB
	SCHEMBL754256	0.82	LIPG (0.49)	LIPGLIPC
	SCHEMBL752899	0.82	LIPG (0.51)	LIPGLIPCALDH1A1POLB
	SCHEMBL752850	0.80	LIPG (0.47)	LIPGLIPC
	SCHEMBL755994	0.80	LIPG (0.49)	LIPGLIPC
	SCHEMBL2489939	0.78	LIPG (0.49)	LIPGLIPC
	SCHEMBL755283	0.77	LIPG (0.47)	LIPGLIPC
	SCHEMBL750864	0.77	LIPG (0.47)	LIPGLIPC
	SCHEMBL2777764	0.77	LIPG (0.48)	LIPGLIPC
	SCHEMBL2778238	0.76	LIPG (0.47)	LIPGLIPC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.